» Articles » PMID: 23188467

Value of Lower Respiratory Tract Surveillance Cultures to Predict Bacterial Pathogens in Ventilator-associated Pneumonia: Systematic Review and Diagnostic Test Accuracy Meta-analysis

Overview
Specialty Critical Care
Date 2012 Nov 29
PMID 23188467
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In ventilator-associated pneumonia (VAP), early appropriate antimicrobial therapy may be hampered by involvement of multidrug-resistant (MDR) pathogens.

Methods: A systematic review and diagnostic test accuracy meta-analysis were performed to analyse whether lower respiratory tract surveillance cultures accurately predict the causative pathogens of subsequent VAP in adult patients. Selection and assessment of eligibility were performed by three investigators by mutual consideration. Of the 525 studies retrieved, 14 were eligible for inclusion (all in English; published since 1994), accounting for 791 VAP episodes. The following data were collected: study and population characteristics; in- and exclusion criteria; diagnostic criteria for VAP; microbiological workup of surveillance and diagnostic VAP cultures. Sub-analyses were conducted for VAP caused by Staphylococcus aureus, Pseudomonas spp., and Acinetobacter spp., MDR microorganisms, frequency of sampling, and consideration of all versus the most recent surveillance cultures.

Results: The meta-analysis showed a high accuracy of surveillance cultures, with pooled sensitivities up to 0.75 and specificities up to 0.92 in culture-positive VAP. The area under the curve (AUC) of the hierarchical summary receiver-operating characteristic curve demonstrates moderate accuracy (AUC: 0.90) in predicting multidrug resistance. A sampling frequency of >2/week (sensitivity 0.79; specificity 0.96) and consideration of only the most recent surveillance culture (sensitivity 0.78; specificity 0.96) are associated with a higher accuracy of prediction.

Conclusions: This study provides evidence for the benefit of surveillance cultures in predicting MDR bacterial pathogens in VAP. However, clinical and statistical heterogeneity, limited samples sizes, and bias remain important limitations of this meta-analysis.

Citing Articles

Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action.

World J Emerg Surg. 2023; 18(1):50.

PMID: 37845673 PMC: 10580644. DOI: 10.1186/s13017-023-00518-3.


The gut microbiota composition is linked to subsequent occurrence of ventilator-associated pneumonia in critically ill patients.

Orieux A, Enaud R, Imbert S, Boyer P, Begot E, Camino A Microbiol Spectr. 2023; :e0064123.

PMID: 37713505 PMC: 10581192. DOI: 10.1128/spectrum.00641-23.


Antimicrobial Resistance in Ventilator-Associated Pneumonia: Predictive Microbiology and Evidence-Based Therapy.

Alnimr A Infect Dis Ther. 2023; 12(6):1527-1552.

PMID: 37273072 PMC: 10240484. DOI: 10.1007/s40121-023-00820-2.


The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic.

Reynolds D, Burnham J, Guillamet C, McCabe M, Yuenger V, Betthauser K Eur Respir Rev. 2022; 31(166).

PMID: 36261159 PMC: 9724833. DOI: 10.1183/16000617.0068-2022.


Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies.

Blot S, Ruppe E, Harbarth S, Asehnoune K, Poulakou G, Luyt C Intensive Crit Care Nurs. 2022; 70:103227.

PMID: 35249794 PMC: 8892223. DOI: 10.1016/j.iccn.2022.103227.


References
1.
Depuydt P, Benoit D, Vogelaers D, Claeys G, Verschraegen G, Vandewoude K . Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures. Intensive Care Med. 2006; 32(11):1773-81. DOI: 10.1007/s00134-006-0354-8. View

2.
Depuydt P, Blot S, Benoit D, Claeys G, Verschraegen G, Vandewoude K . Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med. 2006; 34(3):653-9. DOI: 10.1097/01.CCM.0000201405.16525.34. View

3.
Trouillet J, Chastre J, Vuagnat A, Joly-Guillou M, Combaux D, Dombret M . Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998; 157(2):531-9. DOI: 10.1164/ajrccm.157.2.9705064. View

4.
Aydogdu M, Gursel G, Hizel K, Ozis T . Comparison of the serial surveillance with quantitative and non-quantitative tracheal aspirate in predicting ventilator-associated pneumonia etiology in patients receiving antibiotic therapy. Minerva Anestesiol. 2010; 76(8):600-8. View

5.
Malacarne P, Corini M, Maremmani P, Viaggi B, Verdigi S . Diagnostic characteristics of routine surveillance cultures of endotracheal aspirate samples in cases of late-onset ventilator-associated pneumonia due to Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2007; 28(7):867-9. DOI: 10.1086/518728. View